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Abstract: Several studies have indicated a positive influence of leucine supplementation and aerobic
training on the aging skeletal muscle signaling pathways that control muscle protein balance and
muscle remodeling. However, the effect of a combined intervention requires further clarification.
Thirteen month old CD-1® mice were subjected to moderate aerobic exercise (45 min swimming
per day with 3% body weight workload) and fed a chow diet with 5% leucine or 3.4% alanine for
8 weeks. Serum and plasma were prepared for glucose, urea nitrogen, insulin and amino acid profile
analysis. The white gastrocnemius muscles were used for determination of muscle size and signaling
proteins involved in protein synthesis and degradation. The results show that both 8 weeks of
leucine supplementation and aerobic training elevated the activity of mTOR (mammalian target
of rapamycin) and its downstream target p70S6K and 4E-BP1, inhibited the ubiquitin-proteasome
system, and increased fiber cross-sectional area (CSA) in white gastrocnemius muscle. Moreover,
leucine supplementation in combination with exercise demonstrated more significant effects, such as
greater CSA, protein content and altered phosphorylation (suggestive of increased activity) of
protein synthesis signaling proteins, in addition to lower expression of proteins involved in protein
degradation compared to leucine or exercise alone. The current study shows moderate aerobic
training combined with 5% leucine supplementation has the potential to increase muscle size
in fast-twitch skeletal muscle during aging, potentially through increased protein synthesis and
decreased protein breakdown.
Keywords: leucine-rich diet; aerobic exercise; aging; protein metabolism
Nutrients 2016, 8, 246; doi:10.3390/nu8050246 www.mdpi.com/journal/nutrients
Nutrients 2016, 8, 246 2 of 16
1. Introduction
Aging is a physiological process characterized by progressive decrease in the capacity of organ
systems throughout the organism [1]. Of these changes, skeletal muscle is of particular interest as it
comprises approximately 40%–50% of human body mass and is highly adaptable [2,3]. Sarcopenia
describes the loss of muscle mass and muscle function that occurs during the aging process. When left
untreated, sarcopenia substantially contributes to decreased mobility/autonomy and to an increased
risk of metabolic diseases. Thus, interventions aimed at maintaining muscle mass and function and
attenuating the decline of muscle loss during the aging process are clinically important to sustain an
appropriate quality of life and reduce health care costs in the elderly [4].
Exercise training has been considered an important non-pharmacological intervention for the
treatment of metabolic disorders and loss of skeletal muscle mass in the elderly [5,6]. Resistance
training has been widely recognized as a powerful intervention to maintain or increase skeletal muscle
mass [7,8]. Although not considered the most efficient intervention to stimulate a high magnitude
of muscle hypertrophy, moderate aerobic exercise has demonstrated anti-catabolic properties in
several diseases, like cancer cachexia [9–11], cardiac cachexia [11], and diabetes mellitus [12,13], all of
which are characterized by a loss of muscle mass. In addition, it has been demonstrated that aerobic
exercise increases skeletal muscle protein synthesis (MPS) and strongly activates the mammalian
target of rapamycin (mTOR) pathway in healthy subjects [14–16]. Therefore, modifications in protein
metabolism favoring increased MPS or decreased muscle protein degradation suggests that aerobic
training may be an appropriate intervention option to attenuate the development of sarcopenia.
Due to a higher prevalence of nutrient deficiencies in the elderly, nutritional interventions are
important and efficacious adjuncts to exercise in the promotion of healthy aging [17]. In particular,
several studies have demonstrated higher protein needs in older adults [18–20] due to the development
of anabolic resistance [20,21]. Of the 20 amino acids, leucine alone has been shown to initiate the
translational stage of protein synthesis, and the magnitude of protein synthesis is often directly related
to the leucine content of a particular protein source [20]. Moreover, the addition of leucine to a
lower protein meal is an easy to consume and effective strategy to increase MPS [14,22]. Although
leucine alone is capable of increasing MPS, leucine supplementation combined with resistance training
induces a synergistic effect, resulting in increased MPS and myofibrillar muscle hypertrophy in older
adults [23]. The predominant muscular adaptation to aerobic training is mitochondrial biogenesis [24],
and therefore large changes in myofibrillar protein content have been thought not to occur with leucine
consumption in conjunction with aerobic training; however, the effects of age on the interaction between
aerobic training and leucine supplementation are not yet known. From a molecular standpoint, both
leucine [25] and aerobic exercise [26] have been shown to activate the mTOR pathway, and evidence
exists demonstrating that aerobic training [24] and leucine supplementation [27] decreases muscle
protein degradation. Considering these anti-catabolic effects reported in different muscle wasting
diseases, there is potential for leucine supplementation and aerobic exercise to act synergistically in
aging skeletal muscle to attenuate sarcopenia in mice.
Our objective in this study was to investigate the role of leucine supplementation and aerobic
training in aging skeletal muscle signaling pathways, controlling muscle protein balance and
muscle remodeling.
2. Experimental Section
2.1. Animals and Diets
Forty 13-month-old CD-1® male mice (47–49 g) were obtained from the Chengdu Dashuo
Biological Technology Company (Chengdu, China). All mice were housed in the Laboratory Animal
Center of Chengdu Sport University (Chengdu, China). Light and darkness cycles (12–12 h) and
temperature (22 ˘ 1.5 ˝C) were controlled. Diet and water were available ad libitum. Laboratory animal
bedding materials were renewed 3 times a week; the drinking bottles were disinfected daily. Animal
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welfare and experimental procedures were carried out in accordance with the national and institutional
guidelines, and the study was reviewed and approved by the Institutional Animal Ethics Committee
of Chengdu Sport University, number: 2015/03.
The non-purified diet based on maize, wheat flour, wheat bran, soybean flour, soya bean meal,
rice bran, and fish meal was purchased from the Institute of Experimental Animals, Sichuan Provincial
Academy of Medical Sciences (Chengdu, China). 5% (w/w) L-leucine was added to the intervention diet
by replacing equal amounts of corn flour, while the isonitrogenous control diet contained an added
3.4% (w/w) L-alanine (Table 1). The L-alanine-rich meal was used as the control diet in light of previous
reports that this non-essential amino acid does not affect muscle protein metabolism [28–31].
Table 1. Diet formulation (%).
Feed Composition Basal Diet Leucine Diet Alanine Diet
Corn 22.8 17.8 19.4
Wheat 34.0 34.0 34.0
Wheat bran 10.0 10.0 10.0
Soybean 13.0 13.0 13.0
Soya bean meal 5.0 5.0 5.0
Rice bran 4.0 4.0 4.0
Fish meal 7.0 7.0 7.0
Calcium hydrogen phosphate I 2.4 2.4 2.4
Calcium carbonate 0.6 0.6 0.6
Additives and Microelements 1.2 1.2 1.2
Leucine ~ 5.0 ~
Alanine ~ ~ 3.4
The supplemental dose of 5% L-leucine was used because it has been shown in previous
research to positively regulate the protein synthesis of skeletal muscles [30,31]. Nutrient levels of
the non-purified meal were digestible energy (14.32 MJ/kg), protein (20.6%, w/w), Ca (1.35%, w/w),
total P (1.20%, w/w) and available P (0.97%, w/w). The analyzed contents (%, w/w) of amino acids in the
leucine-supplemented and alanine-supplemented meal are summarized in Table 2.
Table 2. Analyzed contents of amino acids (g/100 g) in the alanine- and leucine-supplemented.
Amino Acid Composition Basal Diet Leucine Diet Alanine Diet
Aspartic acid 1.81 1.72 1.72
Threonine 0.71 0.70 0.71
Serine 0.97 0.94 0.94
Glutamic acid 4.06 4.05 4.01
Glycine 0.97 0.92 0.93
Alanine 1.11 1.04 4.83
Cystine 0.11 0.20 0.17
Valine 0.78 0.79 0.82
Methionine 0.45 0.54 0.50
Isoleucine 0.64 0.62 0.62
Leucine 1.45 6.51 1.42
Tyrosine 0.39 0.47 0.46
Phenylalanine 0.79 0.86 0.86
Lysine 1.17 1.10 1.15
Histidine 0.69 0.62 0.71
Argnine 1.13 1.06 1.04
Proline 1.39 1.30 1.38
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2.2. Experimental Protocols
Forty mice were randomly assigned to four groups with ten mice per group: animals were fed
an alanine-supplemented non-purified diet without exercise intervention (AlaC) or with moderate
physical exercise (AlaE). The other two groups were fed the leucine-supplemented diet combined
with (LeuE) or without (LeuC) exercise, respectively. Body weight and food intake were recorded
every day. The mice were housed in individual cages throughout experimentation. When we renewed
the bedding materials the 6th week, some mice were severely bitten on the face or limbs. Therefore,
to avoid interference of accelerated protein synthesis during the recovery period of injury, the injured
animals were all excluded from the experiment. Thus, only the 33 unharmed mice were included in
the final statistical analysis.
Mice in the AlaE and LeuE groups received moderate intensity swimming exercise in two glass
tanks (100 ˆ 70 ˆ 60 cm) filled with 30 ˘ 2 ˝C water to 40–45 cm depth at once so that the mice could
not have a rest by getting their tail on the bottom of the tank [32]. The exercise protocol consisted
of swimming exercise (45 min/day, 6 day/week) for 8 weeks, with a 3% bodyweight workload that
corresponds to an aerobic intensity of approximately 10%–20% below the anaerobic threshold in
10–12 month old mice. We employed this intensity as it is more reasonable to expect elderly humans
to work at a lower intensity and not near the anaerobic threshold. The loads were readjusted each
day according to the bodyweight of the mice. A monitor was arranged to confirm that all mice were
actually swimming and not engaged in behaviors that minimized the effort exerted, such as floating.
Once the negative activities were observed, the monitor forced the animals to keep swimming with a
glass bar. We randomly measured the blood lactate concentration from the tail vein of mice in the AlaE
and LeuE groups during and immediately after swimming exercise by using a portable blood lactate
analyzer (Lactate pro, Arkray, Kyoto, Japan), and all concentrations were between 2.9 and 3.7 mmol/L.
This suggested that the exercise protocol used was typical of aerobic exercise bouts that may be
employed in elderly humans where blood lactate values have been reported as 2.44 ˘ 1.04 mmol/L
during aquatic aerobics [33].
Twenty-four hours following the final bout of exercise (7 h food deprivation), animals were
euthanized with intraperitoneal injection of pentobarbital sodium (80 mg/kg), after which blood was
collected from the aortaventralis. The blood samples were then centrifuged at 12,000 rpm for 10 min
at 4 ˝C to obtain plasma, or placed at room temperature for 0.5 h and centrifuged at 5000 rpm for
10 min to obtain serum. The superficial portion (white) of gastrocnemius muscles was separated and
washed with PBS, and then the muscle samples were dried using filter paper. After that, samples were
weighed and frozen by liquid nitrogen for western blotting analysis. Specimens from the contralateral
white gastrocnemius were fixed for histological examination.
2.3. Blood Glucose, Serum Insulin, Serum Urea Nitrogen, and Plasma Free Amino Acids Measurement
The blood glucose level was measured from the tail vein of mice using a glucometer
(Johnson OneTouch UltraEasy, Shenzhen, China). The concentration of serum insulin was determined
using a mouse insulin ELISA kit (Mercodia Diagnostics, Uppsala, Sweden). Serum urea nitrogen
analysis was performed using a commercial kit (Jiancheng Bioengineering Institute, Nanjing, China).
Free amino acids in plasma were analyzed using the Hitachi L-8800 amino acid analyzer (Hitachi,
Tokyo, Japan) after acid hydrolysis with 6N HCl (refluxed at 110 ˝C for 24 h) [34].
2.4. Western Blot Analysis
Fifty mg of frozen white gastrocnemius was powdered and homogenized for 30 s in 0.5 mL lysis
buffer (containing protease inhibitors with or without phosphatase inhibitors, accordingly, to detect
the expression of phosphorylated or non-phosphorylated protein). The homogenate was incubated
on ice for 20 min and then centrifuged at 13,000ˆ g at 4 ˝C for 20 min. Supernatants were carefully
transferred to an Eppendorf tube and stored at ´80 ˝C until used for western blots. The protein
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concentration in muscle homogenate was determined with a BCA protein assay kit (Thermo Scientific,
Rockford, IL, USA). A total of 20 µg of protein was loaded per lane, separated by SDS-PAGE (8% or
12%) and transferred to nitrocellulose filter membranes (NC, 0.45 µm). The membranes were blocked
with 3% BSA-TBST for 30 min and incubated overnight at 4 ˝C with mammalian vacuolar protein
sorting mutant 34 (mVPS34, 1:1000 dilution), mTOR (1:1000), phospho-mTOR (Ser2448) (1:1000),
70kDa ribosomal protein S6 kinase (p70S6K, 1:2000), phospho-p70S6K (Thr389) (1:500), eukaryotic
translation initiation factor 4E-binding protein 1 (4E-BP1, 1:2000), phospho-4E-BP1 (Thr37/46) (1:1000),
fast myosin skeletal heavy chain (MHC II, 1:3000), Ubiquitin (1:1000), muscle RING-finger protein-1
(MuRF-1, 1:1000), and muscle atrophy F-box (MAFbx/Atrogin-1, 1:1000) antibodies (Cell Signaling
Technology, Beverly, MA, USA or Abcam, Cambridge, UK) at different dilutions. The next day,
the membranes were incubated at room temperature for 30 min and washed 5 times with tris-buffered
saline with tween 20 (TBST), then incubated with secondary antibody (Jackson Immuno Research,
Laboratories, Inc., West Grove, PA, USA) anti-rabbit (1:20,000) or anti-mice (1:10,000) for 40 min. Blots
were serially washed six times and detected with ECL reagent kit (Merck Millipore, Billerica, MA,
USA). The optical density blotting was analyzed using Totallab (Nonlinear Dynamics, Newcastle,
UK) [35]. The comparisons of both protein expression and phosphorylation rate between groups were
performed with the raw data. The differences were displayed with the relative value, which was
normalized to a control (AlaC).
2.5. Histological Examination
The specimens of white gastrocnemius were fixed with 4% (v/v) paraformaldehyde in 0.01 M
PBS (pH 7.4) for 3 h and embedded in paraffin. Five µm sections were cut and then stained using a
standard haematoxylin and eosin staining method. The images were captured with a 40ˆ objective on
the Olympus DP71 microscope digital camera (Olympus; Tokyo, Japan) and analyzed using Image-Pro
Plus version 6.0 software (Media-Cybernetics, Silver Spring, MD, USA) to measure the cross-sectional
area (CSA) and diameter of muscle fibers [36].
2.6. Statistical Analysis
The normality of the data was checked and subsequently confirmed with the Shapiro–Wilk test.
The Levene’s homogeneity of variance test was used to assess the equality of variances; when Levene’s
test was significant, the Greenhouse–Geisser correction was used. Data that were not normally
distributed were then transformed and retested. Following transformations, data that failed to meet
the assumptions of normality and homogeneity of variances were analyzed with non-parametric tests.
Data are expressed as means plus or minus the standard deviation. When measurements could be
repeated over time (body weight, average daily food intake), repeated measures analysis of variance
was performed. The data of other variables were all analyzed by univariate and two-factor analysis
of variance. When a significant interaction effect was detected, the simple effect was assessed with
the results of one-factor analysis of variance. The significance of the differences between groups was
assessed by Dunnett’s correction for multiple comparisons. All tests were performed using statistical
software SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA), and all figures were created with Sigmaplot
11.0 (Systat, San Jose, CA, USA). Differences were considered as significant for p < 0.05.
3. Results
3.1. Body Weight
The body weight of mice in the two sedentary groups (AlaC, LeuC) were both elevated after
8 weeks when compared with their initial weight; however, only the AlaC group reached statistical
significance (p < 0.05). In comparison, the body weight of mice in the exercise groups did not change
significantly (AlaE, p = 0.132; LeuE, p = 0.136). After the 7 h food deprivation, the body weight of
all mice except LeuE was significantly reduced. Repeated measures ANOVA for data in the 8 week
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experimental period revealed that body weight did not vary with time and the effects of time (week)
did not vary among each group. The multiple comparisons between eight time-points within each
group also showed that the body weight of all mice were stable. A main effect of the intervention was






Figure 1.  (A) Effects of  leucine supplementation and exercise on body weight  (BW); and  (B)  food 
intake. AlaC: alanine supplementation group; LeuC: leucine supplementation group; AlaE: alanine 




suggesting  that  the average daily  food  intake of  the mice  in  each group was  consistent between 
groups throughout the 8 week intervention period (Figure 1B). 
3.3. Concentrations of Serum Insulin, Urea Nitrogen, and Blood Glucose 




LeuC  and  LeuE  were  both  significantly  less  than  AlaE.  Blood  glucose  concentration  was 
significantly greater (p < 0.01)  in AlaC compared to AlaE, and LeuC was significantly greater (p < 
( ) ff ts f i l tation rcise i t );
. l : l i l tation r ; : i t ti ; :
+ exercise train g roup; LeuE: leucine supplementation + exercise training group.
3.2. Food Intake
A significant main effect was found for time (p < 0.05). There were no significant interactions,
suggesting that the average daily food intake of the mice in each group was consistent between groups
throughout the 8 week intervention period (Figure 1B).
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3.3. Concentrations of Serum Insulin, Urea Nitrogen, and Blood Glucose
There were no significant effects of the different interventions on serum insulin. The concentration
of serum urea nitrogen was affected by both leucine supplementation and exercise training (p < 0.01);
however, there were no significant interactions. Compared to AlaC, serum urea nitrogen significantly
decreased in the LeuC, AlaE, and LeuE groups. Post hoc analysis revealed that LeuC and LeuE were
both significantly less than AlaE. Blood glucose concentration was significantly greater (p < 0.01) in
AlaC compared to AlaE, and LeuC was significantly greater (p < 0.01) than LeuE. Exercise significantly







Figure  2.  (A)  Effects  of  leucine  supplementation  and  exercise  on  serum  insulin;  (B)  serum  urea 
nitrogen; and (C) blood glucose in pre‐senescent mice. AlaC: alanine supplementation group; LeuC: 
leucine  supplementation  group; AlaE:  alanine  supplementation  +  exercise  training  group;  LeuE: 
leucine  supplementation  +  exercise  training  group.  Values  are  provided  as  mean  ±  standard 




Regarding  the  main  effects,  the  factor  of  amino  acid  supplementation  only  significantly 
affected  leucine,  alanine,  proline,  glutamic  acid,  glycine,  and  tyrosine, while  exercise  had more 
extensive effects on the concentrations of leucine, isoleucine, arginine, histidine, threonine, alanine, 
serine,  glutamic  acid,  glycine,  and  tyrosine. A  significant  interaction  between  amino  acids  and 
exercise were observed in glutamic acid, glycine, and tyrosine. 
Plasma  concentrations  of  all  essential  amino  acids  except  leucine  were  not  significantly 
affected  by  the  different  interventions.  The  leucine  concentration  in  LeuC, AlaE,  and LeuE was 
higher  than AlaC, with  the greatest values being  in LeuE  (132%),  followed by LeuC  (124%) and 
AlaE  (116%).  In  regard  to  non‐essential  amino  acids,  concentrations  of  alanine,  glutamic  acid, 
glycine,  and  tyrosine  were  significantly  different.  In  the  LeuE  group,  alanine  and  tyrosine 
concentrations were  higher  than mice  in AlaC  (Ala  123%,  Tyr  128%)  and  LeuC  (Ala  147%,  Tyr 
134%), but  lower  than  that  in AlaE. Plasma glutamic  acid  and glycine were  lower  in LeuE  than 
AlaC and AlaE (Table 3). 
Figure 2. (A) Effects of leucine supplementation and exercise on serum insulin; (B) serum urea nitrogen;
and (C) blood glucose in pre-senescent mice. AlaC: alanine supplementation group; LeuC: leucine
supplementation group; AlaE: alanine supplementation + exercise training group; LeuE: leucine
supplementation + exercise training group. Values are provided as mean ˘ standard deviation for each
group (n = 7–10). a: p < 0.05 versus the AlaC group; b: p < 0.01 versus the AlaC group; c: p < 0.05 versus
the LeuC group; d: p < 0.01 versus the LeuC group; e: p < 0.05 versus the AlaE group; f: p < 0.01 versus
the AlaE group.
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3.4. Plasma Free Amino Acids Analysis
Regarding the main effects, the factor of amino acid supplementation only significantly affected
leucine, alanine, proline, glutamic acid, glycine, and tyrosine, while exercise had more extensive effects
on the concentrations of leucine, isoleucine, arginine, histidine, threonine, alanine, serine, glutamic
acid, glycine, and tyrosine. A significant interaction between amino acids and exercise were observed
in glutamic acid, glycine, and tyrosine.
Plasma concentrations of all essential amino acids except leucine were not significantly affected by
the different interventions. The leucine concentration in LeuC, AlaE, and LeuE was higher than AlaC,
with the greatest values being in LeuE (132%), followed by LeuC (124%) and AlaE (116%). In regard
to non-essential amino acids, concentrations of alanine, glutamic acid, glycine, and tyrosine were
significantly different. In the LeuE group, alanine and tyrosine concentrations were higher than mice
in AlaC (Ala 123%, Tyr 128%) and LeuC (Ala 147%, Tyr 134%), but lower than that in AlaE. Plasma
glutamic acid and glycine were lower in LeuE than AlaC and AlaE (Table 3).
Table 3. Mean plasma amino acids concentrations after 8 weeks of leucine supplementation
with/without exercise training (µmol/L).
AlaC (n = 8) LeuC (n = 7) AlaE (n = 10) LeuE (n = 8)
Essential amino acids
Leucine 127.3 ˘ 7.0 158.8 ˘ 5.5 b 148.0 ˘ 9.2 b,c 168.5 ˘ 11.1 b,f
Isoleucine 74.6 ˘ 2.7 73.2 ˘ 3.2 78.7 ˘ 2.7 77.7 ˘ 6.0
Valine 281.0 ˘ 9.2 268.2 ˘ 30.7 279.7 ˘ 2.6 269.2 ˘ 16.4
Arginine 71.5 ˘ 9.2 69.9 ˘ 5.6 78.1 ˘ 4.3 76.5 ˘ 2.5
Histidine 125.1 ˘ 6.6 126.8 ˘ 8.4 132.1 ˘ 3.4 132.4 ˘ 4.5
Lysine 269.2 ˘ 6.4 270.6 ˘ 12.0 277.1 ˘ 14.3 282.5 ˘ 12.5
Methionine 50.7 ˘ 8.5 54.1 ˘ 1.0 56.1 ˘ 9.3 59.1 ˘ 9.2
Phenylalanine 252.2 ˘ 14.8 261.5 ˘ 16.1 266.4 ˘ 12.8 268.0 ˘ 7.0
Threonine 140.9 ˘ 7.1 141.2 ˘ 12.0 148.9 ˘ 11.4 152.6 ˘ 4.9
Non-essential amino
acids
Alanine 306.3 ˘ 33.1 256.0 ˘ 23.3 b 415.7 ˘ 31.9 b,d 378.2 ˘ 21.1 b,d,e
Aspartic acid 147.7 ˘ 13.5 151.4 ˘ 11.8 148.4 ˘ 6.6 158.3 ˘ 14.3
Cystine 47.5 ˘ 5.3 47.8 ˘ 9.3 51.2 ˘ 2.4 53.0 ˘ 5.3
Glutamic acid 465.2 ˘ 28.5 390.8 ˘ 20.2 b 549.3 ˘ 38.0 b,d 406.1 ˘ 26.4 b,f
Glycine 380.6 ˘ 25.4 349.3 ˘ 13.8 a 442.0 ˘ 24.5 b,d 365.7 ˘ 15.7 f
Proline 103.3 ˘ 3.6 107.5 ˘ 6.1 100.2 ˘ 4.9 107.1 ˘ 8.1
Serine 202.2 ˘ 13.2 198.9 ˘ 7.5 210.6 ˘ 9.1 210.4 ˘ 11.2
Tyrosine 94.1 ˘ 5.7 89.4 ˘ 6.8 148.5 ˘ 8.8 b,d 120.5 ˘ 10.8 b,d,f
Values are provided as mean ˘ standard deviation for each group (n = 7–10). AlaC: alanine supplementation
group; LeuC: leucine supplementation group; AlaE: alanine supplementation + exercise training group; LeuE:
leucine supplementation + exercise training group. Glutamic acid shown here includes both glutamine and
glutamic acid. a: p < 0.05 versus the AlaC group; b: p < 0.01 versus the AlaC group; c: p < 0.05 versus the LeuC
group; d: p < 0.01 versus the LeuC group; e: p < 0.05 versus the AlaE group; f: p < 0.01 versus the AlaE group.
3.5. Histological Changes of Muscle Fibers
Compared with the control group (AlaC), histological examination of haematoxylin and eosin
stained white gastrocnemius sections showed significant increases (p < 0.01) in CSA (Figure 3A)
and diameter (Figure 3C) of the muscle fibers in the LeuE group, whereas the CSA and diameter of
these fibers were not changed in LeuC and AlaE (Figure 3E). A main effect of group was found for
gastrocnemius weight (p < 0.05). Gastrocnemius muscle weight was significantly greater (p < 0.01) in
LeuE than LeuC, AlaE, and AlaC (Figure 3B).




Figure  3.  Effects  of  leucine  supplementation  and  exercise  on  (A)  cross‐sectional  area  (CSA),  (B) 
diameter,  (C)  weight,  and  (D)  protein  ratio;  (E)  Hematoxylin‐eosin  stained  sections  of  white 
gastrocnemius  muscle  in  mice:  (a)  Cross‐section  of  alanine  supplementation;  (b)  leucine 
supplementation; (c) alanine supplementation + exercise training; and (d) leucine supplementation + 
exercise  training mice. Magnification  400×,  scale  bars  =  50  μm.  Values  are  provided  as mean  ± 
standard deviation for each group (n = 7–10). AlaC: alanine supplementation group; LeuC: leucine 






AlaC,  the  content  of  white  gastrocnemius  muscle  protein  in  LeuC,  AlaE,  and  LeuE  were  all 
significantly greater (p < 0.01). The differences between LeuC and LeuE, and AlaE and LeuE were 
Figure 3. Effects of leucine supplementation and exercise on (A) cross-sectional area (CSA), (B) diameter,
(C) weight, and (D) protein ratio; (E) Hematoxylin-eosin stained sections of white gastrocnemius
muscle in mice: (a) Cross-section of alanine supplementation; (b) leucine supplementation; (c) alanine
supplementation + exercise training; and (d) leucine supplementation + exercise training mice.
Magnification 400ˆ, scale bars = 50 µm. Values are provided as mean ˘ standard deviation for
each group (n = 7–10). AlaC: alanine supplementation group; LeuC: leucine supplementation group;
AlaE: alanine supplementati n + exercise training group; LeuE: leucine supplementation + exercise
traini g gr up. a: p < 0.05 versus the AlaC group; b: p < 0.01 v rsus th Al C group; c: p < 0.05 versus
the LeuC group; d: p < 0.01 versus the LeuC group; e: p < 0.05 versus the AlaE group; f: p < 0.01 versus
the AlaE group.
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3.6. Total Protein in White Gastrocnemius Muscle
Muscle protein content is reported as mg muscle¨g body weight´1 [37]. When compared with
AlaC, the content of white gastrocnemius muscle protein in LeuC, AlaE, and LeuE were all significantly
greater (p < 0.01). The differences between LeuC and LeuE, and AlaE and LeuE were also significant
(p < 0.01, Figure 3D). The protein content in LeuE was greater than LeuC, AlaE, and AlaC (p < 0.01).
3.7. Protein Expression with Relation to Hypertrophy and Atrophy
AlaE, LeuC, and LeuE all increased (p < 0.01) the protein expression of mVPS34, MHC II and the
phosphorylation state ratio of mTOR (Ser2448), p70S6K (Thr389), and 4E-BP1 (Thr37/46) compared
to AlaC. The main effects of both leucine supplementation and exercise were statistically significant
for all proteins. A significant interaction between these two factors was not found. AlaE, LeuC, and
LeuE all decreased (p < 0.05 or p < 0.01) the protein expression of Ubiquitin, MuRF-1, and Atrogin-1,
which are involved in the ubiquitin-proteasome pathway. Both the leucine and exercise factor showed
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Figure  4. Effects  of  leucine  supplementation  and  exercise  on  protein  expression with  relation  to 
hypertrophy  and  atrophy. AlaC  alanine  supplementation  group,  LeuC  leucine  supplementation 
group, AlaE  alanine  supplementation  +  exercise  training group, LeuE  leucine  supplementation  + 
exercise training group. (A) mVPS34; (B) mammalian target of rapamycin (mTOR); (C) p70S6K; (D) 





protein  breakdown,  which,  in  conjunction  with  reduced  food/protein  intake  and  activity, 
contributes to skeletal muscle atrophy and sarcopenia [1,38]. 
The  enhanced  muscle  CSA,  protein  content,  and  altered  phosphorylation  (suggestive  of 
increased activity) of protein synthesis signaling proteins, and the decreased expression of proteins 
involved in protein degradation observed in LeuC, AlaE, and LeuE in the present study may have 
been  due  to  increased  plasma  amino  acid  concentrations,  as  only  fasting  plasma  free  leucine 
differed  between  groups.  In  this  regard,  both  leucine  supplementation  and  exercise  training 
elevated  leucine  concentrations  in  the  fasting  state. This  elevation observed  in  the  leucine group 
was  not  surprising,  given  that  modifications  in  muscle  branched‐chain  amino  acid  (BCAA) 
metabolism  is  frequently  reported with  leucine  supplementation  [27]. However, exercise  training 
also produced a similar effect [39,40]. This may have been due to reduced leucine uptake by skeletal 
muscle,  as  sufficient  energy  intake  and  available  glucose  leads  to  reduced  leucine  oxidation  in 
skeletal muscle  [10]. Although  increased plasma  leucine  (and BCAA)  levels  has  been  associated 
with metabolic diseases such as obesity and  type 2 diabetes  [27,41], our data does not point  to a 
glucose  homeostasis  disturbance,  as  presented  in  the  Figure  2A,  C.  Although  leucine 
supplementation  and  exercise  training  was  associated  with  increased  plasma  concentration  of 
several  amino  acids,  this  may  have  been  due  to  the  fasting  process  or  as  a  result  of  leucine 
supplementation.  We  can  not  conclude  that  the  protein  breakdown  was  accelerated  due  to 
increased  plasma  alanine  during  the  fasting  state  alone. Moreover,  alanine  concentrations were 
greater  in AlaE compared  to LeuE. This suggests  that  if  the  increased plasma alanine during  the 
fasting  period  was  to  provide  substrate  for  gluconeogenesis,  leucine  supplementation  may 
attenuate  this breakdown. The histological  changes, protein  content of muscles,  and  serum urea 
nitrogen  (see  below)  further  suggests  that  protein  metabolism  was  positively  regulated  when 
moderate aerobic exercise was accompanied by leucine supplementation. 
Both leucine [14,22] and exercise [7,8] have been shown to affect the mTOR pathway in aging 
mice.  mTOR  integrates  the  input  from  multiple  upstream  signaling  pathways,  including 
mechanical  and nutritional  stimulation,  to  regulate  several  eukaryotic  cellular  functions,  such  as 
protein  synthesis  [42]. The up‐regulation  of protein  synthesis  after  leucine  supplementation  and 
exercise  training  is  the  result of  the activation of  the mammalian  target of  rapamycin  complex 1 
. f t l i l t ti i i i i l i
and atrophy. AlaC alanine supplementation group, LeuC l cine supplementation group,
AlaE alanine suppl mentation + exercise train ng group, LeuE leucine supplementation + exercise
training group. (A) mVPS34; (B) mammalian target of r pamycin (mTOR); (C) p70S6K; (D) MuRF-1;
(E) 4E-BP1; (F) MHC; (G) Ubiquitin; and (H) Atrogin-1. Values are provided as mean ˘ tandard
deviation for e ch group (n = 7–10). a: p < 0. 5 versus the AlaC group; b: p < 0.01 versus the AlaC group.
4. Discussion
Aging is a multifactorial process characterized by decreased protein synthesis and increased
protein breakdown, which, in conjunction with reduced food/protein intake and activity, contributes
to skeletal muscle atrophy and sarcopenia [1,38].
The enhanced muscle CSA, protein content, and altered phosphorylation (suggestive of increased
activity) of protein synthesis signaling proteins, and the decreased expression of proteins involved
in protein degradation observed in LeuC, AlaE, and LeuE in the present study may have been
due to increased plasma amino acid concentrations, as only fasting plasma free leucine differed
between groups. In this regard, both leucine supplementation and exercise training elevated leucine
concentrations in the fasting state. This elevation observed in the leucine group was not surprising,
given that modifications in muscle branched-chain amino acid (BCAA) metabolism is frequently
reported with leucine supplementation [27]. However, exercise training also produced a similar
effect [39,40]. This may have been due to reduced leucine uptake by skeletal muscle, as sufficient
energy intake and available glucose leads to reduced leucine oxidation in skeletal muscle [10]. Although
increased plasma leucine (and BCAA) levels has been associated with metabolic diseases such as obesity
and type 2 diabetes [27,41], our data does not point to a glucose homeostasis disturbance, as presented
in the Figure 2A, C. Although leucine supplementation and exercise training was associated with
increased plasma concentration of several amino acids, this may have been due to the fasting process or
as a result of leucine supplementation. We can not conclude that the protein breakdown was accelerated
due to increased plasma alanine during the fasting state alone. Moreover, alanine concentrations were
greater in AlaE compared to LeuE. This suggests that if the increased plasma alanine during the fasting
period was to provide substrate for gluconeogenesis, leucine supplementation may attenuate this
breakdown. The histological changes, protein content of muscles, and serum urea nitrogen (see below)
further suggests that protein metabolism was positively regulated when moderate aerobic exercise
was accompanied by leucine supplementation.
Both leucine [14,22] and exercise [7,8] have been shown to affect the mTOR pathway in aging mice.
TOR integrates the input from multiple upstream signaling pathways, including mechanical and
nutritional stimulation, to regulate several eukaryotic cellular functions, such as protein synthesis [42].
The up-regulation of protein synthesis after leucine supplementation and exercise training is the result
of the activation of the mammalian target of rapamycin complex 1 (mTORC1) and its down-stream
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targets p70S6K and 4E-BP1 [14]. Although chronic low-intensity endurance exercise generally does not
provide enough mechanical overload to induce significant increases in muscle mass, higher-intensity
aerobic exercise training was found to increase muscle protein synthesis and mTOR signaling in older
adults [43]. Konopka and Harber suggest that the effectiveness of aerobic exercise training in inducing
skeletal muscle hypertrophy most likely depends on obtaining a sufficient exercise intensity (70%–80%
heart rate reserve, HRR). However, this intensity may not be appropriate for some older adults, such
as elderly individuals with osteoarthritis, pre-existing injuries, or the frail. Considering the potential
impact of "anabolic resistance" to protein feeding, we assume that leucine combined with lower
intensity aerobic exercise training may confer benefits that otherwise would require higher-intensity
aerobic exercise. Our study demonstrates that pre-senescent mice benefit from aerobic exercise, as
evidenced by muscle remodeling evaluated through histological and biochemical methods. In the
present study, we observed a significant increase in CSA and the ratio of protein to body weight
of LeuE versus AlaC mice. Interestingly, 5% leucine supplementation without exercise also showed
similar effects, as the protein content of white gastrocnemius was elevated by 34% in LeuC versus AlaC.
This is consistent with the findings of previous research that have examined the effects of a leucine-rich
diet on protein synthesis [30,31].
The key upstream proteins of mTOR in the amino acid sensing pathway require further
clarification. Amino acids do not appear to signal through Akt to activate mTORC1 [44]. Instead,
these nutrients signal through other kinases to mTORC1. The Class III PI3K, mammalian vacuolar
protein sorting mutant 34 (mVPS34) has been found to play a critical role in mTORC1 activation [45,46].
MacKenzie et al. [45,46] found that resistance exercise or high-resistance contractions activated mVPS34,
but the effects of aerobic exercise on mVPS34 were not reported. In the present study, the protein
expression of mVPS34 was up-regulated by leucine supplementation and aerobic exercise training, but
there were no significant interactions between these two interventions. Moreover, the phosphorylation
of mTOR, p70S6K, and 4E-BP1 were all increased in LeuC, AlaE, and LeuE mice compared to controls.
These expression changes suggest that protein synthesis in white gastrocnemius is promoted by leucine
supplementation and exercise. Additionally, leucine supplementation without exercise increased
protein expression associated with protein synthesis similarly to those achieved with aerobic exercise.
Skeletal muscle fiber type and contractile function are determined by myosin heavy chain (MHC)
isoforms [47,48]. Contractile phenotype in skeletal muscle fibers is primarily determined by the relative
expression of the MHC isoforms I and II [49]. There is a decrease in the fractional content of MHC II
protein in skeletal muscle, and a corresponding increase in the proportion of MHC I with age, and this
change is consistent with the reduction of CSA occupied by histochemically-typed fast-twitch fibers
in skeletal muscle [50]. We found the protein expression of MHC II, wet weight, diameter, and CSA
of white gastrocnemius was greater for LeuE compared to LeuC, AlaE, and AlaC; however, there
were no differences between LeuC, AlaE, or AlaC. On the other hand, protein concentrations of white
gastrocnemius in LeuC, AlaE, and LeuE mice were significantly increased compared with those of the
control group. Moreover, the CSA and total protein per muscle fiber was the highest in LeuE. These
changes may further suggest that leucine supplementation in conjunction with aerobic exercise training
promotes protein accretion in white gastrocnemius, without affecting variations in skeletal muscle.
The ubiquitin-proteasome system (UPS) is the primary pathway regulating proteolysis in skeletal
muscle and plays a critical role in the control of protein degradation in muscle fibers [51,52].
UPS-dependent protein degradation is known to be highly regulated by exercise and nutrient
availability [53,54]. Two muscle-specific E3 ubiquitin ligases, Atrogin-1 and MuRF1, are considered
to be critical components involved in these regulatory effects [55,56]. Therefore, UPS plays a major
role in controlling skeletal muscle mass in aging [52]. The skeletal muscle atrophy through UPS
arises in the pre-senescent state and shows progressive increases in lean body mass loss with age.
In the present study, mice receiving leucine supplementation and exercise training showed a decrease
in protein expression of ubiquitin, Atrogin-1, and MuRF-1, and the combination of leucine and
exercise led to more significant decreases compared with exercise or leucine supplementation alone.
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We previously demonstrated diminished gene expression of Atrogin-1 and MuRF-1 after a chronic
program of resistance training in rats [57]. This study demonstrates for the first time that aerobic
training or leucine supplementation is also capable of inhibiting both atrogenes, with a more significant
inhibition observed when leucine supplementation is combined with aerobic training. The inhibition
of UPS components with leucine and exercise suggests that protein degradation in pre-senescent
mice was decreased, and therefore may play a role in maintaining skeletal muscle mass. Additionally,
serum urea nitrogen was also lower in the leucine and exercise group suggesting improved nitrogen
balance. Therefore, the greater muscle mass we observed in LeuE compared to AlaC is likely most
attributable to the potential synergistic effects of leucine supplementation and exercise on inhibiting
muscle protein breakdown.
5. Conclusions
In conclusion, long-term leucine supplementation, swimming exercise training, and combined
interventions are potential treatments to enhance white gastrocnemius mass in pre-senescent mice,
with the combination of leucine and exercise showing the greatest effects. These results may have been
achieved by stimulating protein synthesis, but are predominantly attributable to inhibiting muscle
protein degradation. Interestingly, in our sample of mice, leucine supplementation alone showed
similar effects to aerobic training; however, more human data is needed to translate these effects. From
a molecular mechanistic standpoint, mVPS34/mTOR and UPS may be involved in these regulatory
effects induced by leucine and/or exercise, and the leucine availability may also play a central role in
this process. Further research is needed to investigate the use of inhibitors or blockers of these critical
signaling proteins (i.e., mVPS34, mTOR, Atorgin-1, and MuRF-1), as they were not utilized in this
work. Future research should also investigate the dose–effect relationship of leucine supplementation
and exercise training (including intensity and duration) in aging populations. Finally, we acknowledge
that this research was limited by the lack of muscle function testing, because increased muscle mass
has not always positively correlated with muscle function. Thus, the effects of different interventions
on measures of muscle function such as maximal force output and peak power will be potentially
fruitful areas of future research.
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